Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1996 1
1997 3
1998 4
1999 1
2000 2
2004 1
2009 1
2014 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Vitrectomy for retained lens fragments after phacoemulsification.
Margherio RR, Margherio AR, Pendergast SD, Williams GA, Garretson BR, Strong LE, Trese MT, Cox MS, Hassan TS. Margherio RR, et al. Among authors: pendergast sd. Ophthalmology. 1997 Sep;104(9):1426-32. doi: 10.1016/s0161-6420(97)30120-1. Ophthalmology. 1997. PMID: 9307637
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration.
Coney JM, Zubricky R, Sinha SB, Sonbolian N, Zhou L, Hull TP, Lewis SA, Miller DG, Novak MA, Pendergast SD, Pham H, Platt SM, Rao LJ, Schartman JP, Singerman LJ, Donkor R, Fink M, McCoy J, Karcher H. Coney JM, et al. Among authors: pendergast sd. Int J Retina Vitreous. 2023 Feb 1;9(1):8. doi: 10.1186/s40942-023-00445-0. Int J Retina Vitreous. 2023. PMID: 36726178 Free PMC article.
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
Coney JM, McCoy JE, Buxy Sinha S, Sonbolian N, Zhou L, Hull TP, Lewis SA, Miller DG, Novak MA, Pendergast SD, Pham H, Platt SM, Rao LJ, Schartman JP, Singerman LJ, Donkor R, Fink M, Zubricky R, Karcher H. Coney JM, et al. Among authors: pendergast sd. Clin Ophthalmol. 2023 Nov 23;17:3601-3611. doi: 10.2147/OPTH.S432957. eCollection 2023. Clin Ophthalmol. 2023. PMID: 38026599 Free PMC article.
The effects of scleral buckling on young rabbit eyes.
Moshfeghi AA, Pendergast SD, Hartzer MK, Ferrone PJ. Moshfeghi AA, et al. Among authors: pendergast sd. Arch Ophthalmol. 2004 Apr;122(4):473-6. doi: 10.1001/archopht.122.4.473. Arch Ophthalmol. 2004. PMID: 15078663
Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.
Wroblewski JJ, Wells JA 3rd, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM; Pegaptanib in Central Retinal Vein Occlusion Study Group. Wroblewski JJ, et al. Arch Ophthalmol. 2009 Apr;127(4):374-80. doi: 10.1001/archophthalmol.2009.14. Arch Ophthalmol. 2009. PMID: 19365011 Clinical Trial.
19 results